S'abonner

2020 webPOISONCONTROL data summary - 16/03/22

Doi : 10.1016/j.ajem.2022.02.014 
Nicole E. Reid, BSN, EdM a, b, Kelly Johnson-Arbor, MD a, c, d, Susan Smolinske, PharmD a, e, f, Toby Litovitz, MD a, b, d,
a National Capital Poison Center, Washington, DC, United States of America 
b The George Washington University School of Medicine, Washington, DC, United States of America 
c MedStar Georgetown University Hospital, Washington, DC, United States of America 
d Georgetown University School of Medicine, Washington, DC, United States of America 
e College of Pharmacy, University of New Mexico, Albuquerque, NM, United States of America 
f New Mexico Poison and Drug Information Center, University of New Mexico, Albuquerque, NM, United States of America 

Corresponding author at: National Capital Poison Center, Washington, DC, United States of America.National Capital Poison CenterWashington, DCUnited States of America

Abstract

Introduction

Increasing use of the internet for health information has decreased utilization of traditional telephone-based poison centers in the United States. webPOISONCONTROL®, a browser-based tool and app was launched to meet the growing demand for online, personalized recommendations for human poison exposures. This study was conducted to characterize webPOISONCONTROL cases and highlight its potential for real-time monitoring of poisoning.

Methods

Case data for all completed, nonduplicated public cases entered in 2020 were analyzed using a custom Qlik Sense dashboard.

Results

Of the 156,202 cases, 52.9% occurred in children younger than 4 years. Most cases (109,057, 69.8%) were initially triaged to home, 28.4% were advised to call Poison Control, and 1.7% were referred to the ED. Follow-up was available for 33.3% of home-triaged cases; 1.7% of those had a change in triage recommendation.

Pharmaceuticals were implicated in 41.5% of cases (nonpharmaceuticals in 58.5%). Ingestion was the most common route (88.4%, 138,012). One-time double dose therapeutic error cases were implicated in 17,901 cases (27.6% of pharmaceutical cases). Cosmetics (13.9%) and cleaning substances (12.9%) were the most frequent substance categories. Melatonin was the most frequently implicated generic substance (4.5% of cases). Most (72.0%) cases had no effect (21.4%), a minor effect (3.9%) or were minimally toxic with unknown outcome (46.7%). There were no deaths, 17 major outcomes (0.01%), and 26.7% of cases had potentially toxic exposures with no outcome determination.

In 2020, webPOISONCONTROL handled 7.3% as many human poison exposure cases as were reported to U.S. phone-based poison centers. Online cases are skewed towards younger ages (53% in children younger than 4 years vs 37% of phone-based cases) and towards nonpharmaceuticals (58.5% vs 43.5%). Near real-time data visualizations enabled detection of COVID-19-related increases in exposures to hand sanitizers and cleaners, illustrating the public health surveillance and hazard detection capabilities of webPOISONCONTROL.

Conclusion

The webPOISONCONTROL tool provides a safe, quick and fully-automated alternative to those who are unable or unwilling to use the telephone to call a traditional poison center.

Le texte complet de cet article est disponible en PDF.

Keywords : Poison control centers, Poisoning epidemiology, Online access to poison control, Population surveillance, Internet-based intervention


Plan


© 2022  The Authors. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 54

P. 184-195 - avril 2022 Retour au numéro
Article précédent Article précédent
  • Emergency medicine pharmacist interventions reducing exposure to costs (EMPIRE-C)
  • Scott K. Dietrich, Ben T. Bushong, Elisabeth A. Schneider-Smith, Mark A. Mixon
| Article suivant Article suivant
  • The impact of COVID-19 on the patterns of emergency department visits among pediatric patients
  • Seonji Kim, Young Sun Ro, Sung-keun Ko, Taehui Kim, Yun-Suk Pak, So-Hyun Han, Sungwoo Moon

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.